Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in the Treatment of Plane Warts
NCT07710638Phase 2Completed
- Sponsor
- Al-Azhar University
- Start
- Jun 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial of CHILD-IVITAB in flat warts (4 arms), sponsored by Al-Azhar University. Primary endpoint: Percentage of patients achieving complete clearance of plane warts at 3 months. Started Jun 2025; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
flat warts
Beyond the preview
Go deeper on NCT07710638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710638.